Omega-3s continue to challenge established solutions in cardiovascular science.

Omega-3 Therapy

Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth and Final Cohort of Patients in the EnACT Trial of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis

See more

Contact us